Literature DB >> 26569183

What people want from sex and preexposure prophylaxis.

Robert M Grant1, Kimberly A Koester.   

Abstract

PURPOSE OF REVIEW: As demand for preexposure prophylaxis (PrEP) increases, we are learning more about what people want from sex and PrEP. RECENT
FINDINGS: PrEP demand has reached a tipping point in the USA and is increasing rapidly. Although the primary benefit of PrEP use is biological, to reduce risk of HIV infection, PrEP users often express an alternative set of social and emotional benefits that are provided by PrEP. These collateral benefits of PrEP have salience, affect, and are experienced in the present, which are compelling drivers of human behavior. PrEP use has been associated with feeling safe during sex, usually in contrast to ruminations related to fear of HIV or intimate partner violence or control. PrEP can create empowerment, or agency, defined as the capacity and autonomy to act on one's own behalf, because it provides control over one's vulnerability to HIV and relief to women and men who may otherwise worry about whether their partners will use a condom, take antiretroviral therapy, or disclose their HIV status accurately. Planning for sexual and social goals in calm moments is also empowering. These highly desired collateral benefits of PrEP could be undermined, or eliminated, if PrEP is implemented in ways that are coercive or that foment fear of sexual risk compensation, drug resistance, toxicity, or moral judgment.
SUMMARY: Current PrEP implementation provides direct and indirect benefits that are highly desired.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26569183      PMCID: PMC6446930          DOI: 10.1097/COH.0000000000000216

Source DB:  PubMed          Journal:  Curr Opin HIV AIDS        ISSN: 1746-630X            Impact factor:   4.283


  29 in total

1.  Should I Convince My Partner to Go on Pre-Exposure Prophylaxis (PrEP)? The Role of Personal and Relationship Factors on PrEP-Related Social Control among Gay and Bisexual Men.

Authors:  Steven A John; Tyrel J Starks; H Jonathon Rendina; Christian Grov; Jeffrey T Parsons
Journal:  AIDS Behav       Date:  2018-04

2.  Making an Impact With Preexposure Prophylaxis for Prevention of HIV Infection.

Authors:  Jared M Baeten
Journal:  J Infect Dis       Date:  2016-07-14       Impact factor: 5.226

3.  Body/Selves and Beyond: Men's Narratives of Sexual Behavior on PrEP.

Authors:  Shana D Hughes; Nicolas Sheon; Erin V W Andrew; Stephanie E Cohen; Susanne Doblecki-Lewis; Albert Y Liu
Journal:  Med Anthropol       Date:  2018-01-19

Review 4.  PrEP Stigma: Implicit and Explicit Drivers of Disparity.

Authors:  Sarit A Golub
Journal:  Curr HIV/AIDS Rep       Date:  2018-04       Impact factor: 5.071

Review 5.  Next-Wave HIV Pre-Exposure Prophylaxis Implementation for Gay and Bisexual Men.

Authors:  Sarit A Golub; Julie E Myers
Journal:  AIDS Patient Care STDS       Date:  2019-05-16       Impact factor: 5.078

6.  Risk Perception, Sexual Behaviors, and PrEP Adherence Among Substance-Using Men Who Have Sex with Men: a Qualitative Study.

Authors:  Erik D Storholm; Jonathan E Volk; Julia L Marcus; Michael J Silverberg; Derek D Satre
Journal:  Prev Sci       Date:  2017-08

7.  Efficacy of oral pre-exposure prophylaxis (PrEP) for HIV among women with abnormal vaginal microbiota: a post-hoc analysis of the randomised, placebo-controlled Partners PrEP Study.

Authors:  Renee Heffron; R Scott McClelland; Jennifer E Balkus; Connie Celum; Craig R Cohen; Nelly Mugo; Elizabeth Bukusi; Deborah Donnell; Jairam Lingappa; James Kiarie; Tina Fiedler; Matthew Munch; David N Fredricks; Jared M Baeten
Journal:  Lancet HIV       Date:  2017-07-18       Impact factor: 12.767

8.  Sex Hormone Therapy and Tenofovir Diphosphate Concentration in Dried Blood Spots: Primary Results of the Interactions Between Antiretrovirals And Transgender Hormones Study.

Authors:  Robert M Grant; Marion Pellegrini; Patricia A Defechereux; Peter L Anderson; Michelle Yu; David V Glidden; Joshua O'Neal; Jenna Yager; Shalender Bhasin; Jae Sevelius; Madeline B Deutsch
Journal:  Clin Infect Dis       Date:  2021-10-05       Impact factor: 20.999

9.  Words Matter: Putting an End to "Unsafe" and "Risky" Sex.

Authors:  Julia L Marcus; Jonathan M Snowden
Journal:  Sex Transm Dis       Date:  2020-01       Impact factor: 3.868

10.  Treating risk, risking treatment: experiences of iatrogenesis in the HIV/AIDS and opioid epidemics.

Authors:  Lauren Textor; William Schlesinger
Journal:  Anthropol Med       Date:  2021-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.